Tritonix.ai

News / Taiwan / economic_daily

TWSE Fines Guangli-KY NT$50,000 for Delayed Financial Disclosure

Health Technology · Biotechnology · economic_daily · 2026-08-25

6431

Guangli-KY has been fined NT$50,000 by the Taiwan Stock Exchange for failing to timely disclose information regarding its second-quarter financial report board meeting.

What Happened

Violation Details: Guangli-KY failed to timely disclose a material event regarding its board meeting scheduled for August 26, 115, to approve the second-quarter financial results. The company was expected to report this information by August 19 but missed the regulatory deadline.

Regulatory Penalty: The Taiwan Stock Exchange (TWSE) determined that the company breached Article 4, Paragraph 1, Subparagraph 31 of the Procedures for Verification and Disclosure of Material Information. Consequently, the exchange imposed a fine of NT$50,000 on the company.

Compliance Mandate: The TWSE has issued a formal notice to Guangli-KY, mandating that the company improve its internal procedures. The exchange emphasized that future disclosures must strictly adhere to regulatory requirements to ensure market transparency.

Market Impact: While the financial penalty is relatively minor, it highlights the importance of corporate governance and timely reporting for listed companies. Investors are advised to monitor the company's future compliance efforts and the accuracy of its financial reporting processes.

Read original

More in Health Technology

Taiwan Stocks Face Volatility as Nvidia Earnings and Fed Policy Loom; Pei-Er Biomedical Hits Record High

Health Technology · economic_daily · 2026-08-25

Taiwan stocks retreated as investors braced for Nvidia's earnings and Fed commentary, while biotech firm Pei-Er Biomedical bucked the trend to reach a new record.

2059, 3231, 5274, 6446, 6949

DS Investment Securities Raises Hanmi Pharmaceutical Target Price on Obesity Drug Licensing Deal

Health Technology · yonhap_finance · 2026-08-24

DS Investment Securities raised Hanmi Pharmaceutical's target price to 720,000 KRW, citing increased clinical success potential following a major licensing deal.

128940

PharmaEssentia's Ropeg Secures Regulatory Approval in Japan for ET Treatment

Health Technology · economic_daily · 2026-08-24

PharmaEssentia's innovative interferon Ropeg has received approval from Japan's MHLW for the treatment of essential thrombocythemia, covering all patient segments.

6446

Latest in Taiwan

Taiwan Stocks Stage Massive Late-Session Rebound: Who Is Buying?

Electronic Technology · economic_daily · 2026-08-25

Taiwan stocks saw a dramatic 1,000-point swing in late trading as local investors stepped in to support the market, signaling a healthier long-term outlook.

Powertech Technology Reports Progress on Share Buyback Program

Electronic Technology · economic_daily · 2026-08-25

Powertech Technology has disclosed that it has repurchased 1.58 million shares for NT$419 million, signaling management's confidence in the firm's outlook.

6239

TWSE Partners with Fubon Securities to Host Earnings Presentations at SEMICON Taiwan

Electronic Technology · economic_daily · 2026-08-25

The Taiwan Stock Exchange will collaborate with Fubon Securities to host a series of earnings presentations and industry seminars at SEMICON Taiwan on September 3rd, featuring seven listed companies and expert insights.

3583, 4770, 5434, 6854, 7610, 7730, 7823

TWSE Overhauls Trading Rules: Tick Size for High-Priced Stocks Cut to NT$1 and Default Penalties Tightened

Finance · economic_daily · 2026-08-25

The Taiwan Stock Exchange has approved major regulatory changes, including reducing the tick size for stocks over NT$1,000 to NT$1 and extending the monitoring period for defaulting investors to five years.